← Leaderboards
Cristina Sophia Albott
University Of Minnesota
$1,003,585
Attributed
$1,003,585
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $200.7K · FY2020–24$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,003,585 · 1
By mechanism
K23$1,003,585 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Dickson Ally Mkoka$2,627,641
- Alik S Widge$14,097,428
- Jocelyn M Richard$5,008,686
- Jonathan Gewirtz$1,888,065
- Steven E Patterson$9,957,982
Others in their field
Other Emerging Leaders on “Improved Outcome”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$145,933,707
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Scott Hensley · University Of Pennsylvania$44,383,572
- Abraham Aizer Brody · New York University School Of Medicine$39,891,529
Research focus
Improved OutcomeImpairmentBilateralHigh Risk PopulationImpaired CognitionAftercareChronic StressClinical PredictorsAmygdaloid StructureGrantBiological FactorsCohortComorbidityDepressed MoodDesignDisabilityDisease ModelExecutive DysfunctionClinical ResearchBiologicalCognitionFunctional DisorderCognitive FunctionInfusion Procedures
Grant awards (5)
Characterization of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine Probe$200,710
K23 · FY2024 · MH · contact PI
Characterization of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine Probe$200,733
K23 · FY2023 · MH · contact PI
Characterization of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine Probe$200,709
K23 · FY2022 · MH · contact PI
Characterization of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine Probe$200,727
K23 · FY2021 · MH · contact PI
Characterization of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine Probe$200,706
K23 · FY2020 · MH · contact PI